白介素15(IL15)重組蛋白
Recombinant Interleukin 15 (IL15)
- 編號RPA061Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位細(xì)胞核, 分泌, 細(xì)胞質(zhì)
- 預(yù)測分子量14.2kDa
- 實(shí)際分子量18/16/14kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Trp50~Ser162 with N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)5.1
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1344¥ 3360¥ 6720¥ 20160¥ 50400
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. Gene Sequencing (Extract)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| APA061Hu01 | 白介素15(IL15)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA061Hu01 | 白介素15(IL15)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA061Hu01 | 白介素15(IL15)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA061Hu71 | 白介素15(IL15)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| RAA061Hu21 | 白介素15(IL15)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
| MAA061Hu21 | 白介素15(IL15)單克隆抗體 | WB |
| MAA061Hu22 | 白介素15(IL15)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA061Hu | 白介素15(IL15)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| MEA061Hu | 白介素15(IL15)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA061Hu | 白介素15(IL15)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| IGA061Hu21 | 白介素15(IL15)人基因嵌入小鼠 | 動物實(shí)驗(yàn)，陽性對照。 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Endocrine | Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training[Pubmed: 24006180] |
| Endocrine | Time course of IL-15 expression after acute resistance exercise in trained rats: effect of diabetes and skeletal muscle phenotype[Pubmed:25522723] |
| Med Sci Moni | miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice[PubMed: 26087886] |
| Exercise physiology | Effects of intrinsic aerobic capacity, aging and physical activity on interleukin-15 protein level in serum and skeletal muscle[Dspace: Handle] |
| Biotechnology Letters | Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice[s10529-017-2342-1] |
| Journal?of?Controlled?Release | Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy.[pubmed:28408199] |